SCHEMBL3161165

SCHEMBL3161165

CC(=O)NCCNc1cc(NC(=O)C(=O)N2CCN(c3ccc(C#N)cc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 10/20 0.45
▸ ABCB1 P08183 7/20 0.45
▸ ABCC1 P33527 2/20 0.45
▸ USP2 O75604 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CLK4 Q9HAZ1 1/20 0.45
▸ EP300 Q09472 1/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ ADORA2B P29275 2/20 0.39
▸ ADORA2A P29274 2/20 0.39
▸ ADORA1 P30542 2/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ NAMPT P43490 2/20 0.39
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3166495 0.92 SLC1A2 (0.44) USP2CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL3155601 0.90 ADORA2A (0.42) USP2CYP1A2CYP3A4CLK4ADORA2B
SCHEMBL3162484 0.90 MAPT (0.44) CHRM4ADORA2BADORA2AADORA1ADORA3
SCHEMBL3163864 0.89 LMNA (0.43) USP2ADORA2BADORA2AADORA1ADORA3
SCHEMBL3164671 0.88 ADORA2A (0.41) USP2CYP1A2CYP3A4CLK4ADORA2B
SCHEMBL3171368 0.88 ADORA3 (0.45) USP2ADORA2BADORA2AADORA1ADORA3
SCHEMBL3165360 0.88 PHGDH (0.43) ABCG2ABCB1ABCC1USP2CYP1A2
SCHEMBL3260451 0.88 SLC1A2 (0.52) USP2CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL3174104 0.87 ADORA2A (0.41) CYP1A2CYP3A4CLK4ADORA2BADORA2A
SCHEMBL3175769 0.85 ADORA2A (0.45) USP2CYP1A2CYP3A4CYP2D6CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback